Cargando…

Oral Atenolol versus Propranolol in the Treatment of Infantile Hemangioma: A Systematic Review and Meta-Analysis

BACKGROUND: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. Propranolol is considered first-line therapy for IH. However, it is associated with side effects. Therefore, there was a need for alternative therapy. Atenolol, a selective b1-blocker may be free from such sid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pattanshetti, Swapnil Annasaheb, Mahalmani, Vidya M, Sarma, Phulen, Kaur, Hardeep, Ali, Md Mokkaram, Malik, Muneer Abas, Peters, Nitin James, Prajapat, Manisha, Kumar, Subodh, Medhi, Bikash, Samujh, Ram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208683/ https://www.ncbi.nlm.nih.gov/pubmed/35733601 http://dx.doi.org/10.4103/jiaps.jiaps_3_21

Ejemplares similares

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health
por: Hermans, Mireille M., et al.
Publicado: (2023)

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)

Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
por: Seebauer, Caroline T., et al.
Publicado: (2022)

Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2022)

In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
por: Prajapat, Manisha, et al.
Publicado: (2020)

Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2023)

Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
por: Kaur, Hardeep, et al.
Publicado: (2021)

Role of Iron Chelators in Mucormycosis
por: Mahalmani, Vidya, et al.
Publicado: (2021)

Positive list of antibiotics and food products: Current perspective in India and across the globe
por: Mahalmani, Vidya M., et al.
Publicado: (2019)

Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trials
por: Kaur, Hardeep, et al.
Publicado: (2023)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
por: Kumar, Subodh, et al.
Publicado: (2021)

Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
por: HERMANS, Mireille M., et al.
Publicado: (2022)

Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021)

Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)

When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)

Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)

Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020)

Drug targets for corona virus: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020)

Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial
por: Ashraf, Raihan, et al.
Publicado: (2023)

Update on the target structures of SARS-CoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020)

Update on geographical variation and distribution of SARS-nCoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2021)

A preliminary study to evaluate the behavior of Indian population toward E-pharmacy
por: Bansal, Seema, et al.
Publicado: (2022)

Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis
por: Liu, Zhuang, et al.
Publicado: (2020)

Current status of in silico, preclinical and clinical study registries across the globe: A systematic review and meta-analysis
por: Kaur, Hardeep, et al.
Publicado: (2021)

Oral atenolol therapy for proliferating infantile hemangioma: A prospective study
por: Ji, Yi, et al.
Publicado: (2016)

Variable Response to Propranolol Therapy for Infantile Hemangiomas
por: Jain, Vishesh, et al.
Publicado: (2012)

Excellent response of infantile orbital hemangioma to propranolol
por: Sendrasoa, Fandresena A, et al.
Publicado: (2016)

Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas
por: Praticò, Andrea Domenico, et al.
Publicado: (2015)

Propranolol therapy for infantile hemangioma: our experience
por: Zhang, Ling, et al.
Publicado: (2017)

Commentary: Propranolol for infantile hemangiomas — The intralesional route
por: Tripathy, Devjyoti
Publicado: (2019)

Propranolol-induced hyperkalemia in the management of infantile hemangioma
por: Al-Rwebah, Huda, et al.
Publicado: (2020)

Severe hypoglycemia in propranolol treatment for infantile hemangiomas
por: Morimoto, Akira, et al.
Publicado: (2022)

In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
por: Shekhar, Nishant, et al.
Publicado: (2020)

Indian contribution toward biomedical research and development in COVID-19: A systematic review
por: Kaur, Hardeep, et al.
Publicado: (2021)

COVID-19 pandemic: A review based on current evidence
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4sam7nffanmjeufdbdo1cg67oj